CGEM Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Cullinan Oncology Inc - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 25.3 USD 31.43%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast CGEM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CGEM is 26.86 USD with a low forecast of 19.19 USD and a high forecast of 37.8 USD.

CGEM Lowest Forecast

Wall Street Target

CGEM Average Forecast

Wall Street Target

CGEM Highest Forecast

Wall Street Target

24% Downside

6% Upside

49% Upside

The latest public price target was made on Apr 17, 2024 by Kaveri Pohlman from BTIG , who expects CGEM stock to rise by 19% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst	Price Target	Date	Article
Kaveri Pohlman BTIG	30 USD Upside 19%	1 week ago Apr 17, 2024	Cullinan Oncology Inc. (CGEM) PT Raised to $30 at BTIG StreetInsider
Edward White H.C. Wainwright	29 USD Upside 15%	1 week ago Apr 16, 2024	Cullinan Oncology price target lowered to $29 from $34 at H.C. Wainwright TheFly
Unknown Analyst Morgan Stanley	19 USD Downside 25%	1 year ago Feb 3, 2023	Morgan Stanley Maintains Overweight on Cullinan Oncology, Lowers Price Target to $19 Benzinga

Price Target	30 USD
Upside/Downside	19%

Price Target	29 USD
Upside/Downside	15%

Price Target	19 USD
Upside/Downside	25%

Genenta Science SPA

806% Upside

PYC Therapeutics Ltd

278% Upside

Sera Prognostics Inc

74% Downside

Sunshine Guojian Pharmaceutical Shanghai Co Ltd

41% Upside

Genenta Science SPA

806% Upside

PYC Therapeutics Ltd

278% Upside

Sera Prognostics Inc

74% Downside

Sunshine Guojian Pharmaceutical Shanghai Co Ltd

41% Upside

Bioporto A/S

319% Upside

Lyell Immunopharma Inc

182% Upside

XBiotech Inc

129% Upside

Vir Biotechnology Inc

300% Upside

Revenue
Forecast

N/A

N/A

N/A

N/A

What are analyst estimates?

Operating Income
Forecast

N/A

N/A

20%

What are analyst estimates?

Net Income
Forecast

N/A

N/A

-3%

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for CGEM is 26.86 USD with a low forecast of 19.19 USD and a high forecast of 37.8 USD.

Join more than 132,400+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.